Background To assess the impact of a quadrivalent human papillomavirus vaccine (4HPV)
in women at increased risk of genital warts (GWs) acquisition. Methods The study was …

Genital warts (GWs) caused by the human papilloma virus (HPV) are a significant health
problem due to high prevalence and rate of recurrence. Bivalent vaccine has been used …

Introduction Evidence of human papillomavirus (HPV) vaccine impact on anogenital warts
(AGWs) by race or urbanicity in the US is lacking. We evaluated HPV vaccine impact in …

Methods During 6 month (February 2010-July 2010) 20 private gynaecological centers in all
Czech Republic were counting up the number of genital warts cases. Risk factors, therapy …

Objectives To estimate the total number of cases of, and cost of care for, genital warts (GWs)
in England, to inform economic evaluations of human papillomavirus vaccination. Methods …

Because of the rapid development of genital warts (GW) after infection, monitoring GW
trends may provide early evidence of population-level human papillomavirus (HPV) vaccine …

Objective To measure the effect on genital warts of the national human papillomavirus
vaccination programme in Australia, which started in mid-2007. Design Trend analysis of …

Background. Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …

Introduction The HIV epidemic in Latin America is concentrated among men who have sex
with men (MSM) and transgender women (TGW) with transmission predominately occurring …

Background This study aimed to estimate the prevalence of genital warts in Taiwan among
those seeking healthcare, as well as genital-warts-related healthcare resource use and …